Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production
DOI: https://doi.org/10.2147/IJN.S377371
IF: 7.033
2022-09-24
International Journal of Nanomedicine
Abstract:Kathryn M Luly, 1, 2 Huilin Yang, 2, 3 Stephen J Lee, 2, 3 Wentao Wang, 1, 2 Seth D Ludwig, 2, 3 Haley E Tarbox, 4 David R Wilson, 1, 2, 5 Jordan J Green, 1– 3, 5– 10 Jamie B Spangler 1– 3, 6, 8 1 Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2 Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3 Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA; 4 Department of Chemistry, Johns Hopkins University, Baltimore, MD, USA; 5 Institute for Nanobiotechnology, Johns Hopkins University, Baltimore, MD, USA; 6 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 7 Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 8 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 9 Departments of Neurosurgery and Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 10 Department of Materials Science & Engineering, Johns Hopkins University, Baltimore, MD, USA Correspondence: Jamie B Spangler, Departments of Biomedical Engineering and Chemical & Biomolecular Engineering, Johns Hopkins University, 400 N Broadway, Smith 5011, Baltimore, MD, 21231, USA, Tel +1 443 287-1708, Email Jordan J Green, Department of Biomedical Engineering, Johns Hopkins University School of Medicine, 400 N Broadway, Smith 5017, Baltimore, MD, 21231, USA, Tel +1 410 614-9113, Email Purpose: Transient transfection is an essential tool for recombinant protein production, as it allows rapid screening for expression without stable integration of genetic material into a target cell genome. Poly(ethylenimine) (PEI) is the current gold standard for transient gene transfer, but transfection efficiency and the resulting protein yield are limited by the polymer's toxicity. This study investigated the use of a class of cationic polymers, poly(beta-amino ester)s (PBAEs), as reagents for transient transfection in comparison to linear 25 kDa PEI, a commonly used transfection reagent. Methods: Transfection efficiency and protein production were assessed in human embryonic kidney 293F (HEK) and Chinese hamster ovary-S (CHO) cell suspensions using PBAE-based nanoparticles in comparison to linear 25 kDa PEI. Production of both a cytosolic reporter and secreted antibodies was investigated. Results: In both HEK and CHO cells, several PBAEs demonstrated superior transfection efficiency and enhanced production of a cytosolic reporter compared to linear 25 kDa PEI. This result extended to secreted proteins, as a model PBAE increased the production of 3 different secreted antibodies compared to linear 25 kDa PEI at culture scales ranging from 20 to 2000 mL. In particular, non-viral gene transfer using the lead PBAE/plasmid DNA nanoparticle formulation led to robust transfection of mammalian cells across different constructs, doses, volumes, and cell types. Conclusion: These results show that PBAEs enhance transfection efficiency and increase protein yield compared to a widespread commercially available reagent, making them attractive candidates as reagents for use in recombinant protein production. Keywords: non-viral gene transfer, transient transfection, mammalian cell expression systems, DNA delivery Current research into chemical-based transfection methods focuses largely on optimizing agents for use in the development and production of recombinant proteins. Transient transfection, in which introduced genetic material is not incorporated into the host genome, is especially useful during the high-throughput design and screening of proteins (eg, candidate biologics) wherein stable expression is not needed. While culture conditions and plasmid design have been popular targets for optimization in transient transfection workflows, 1,2 many proteins remain difficult to express via transient transfection, and thus development of improved transfection reagents is needed to boost protein yields for applications in biomedical research and pharmaceutical design. In particular, discovery and development of next-generation antibody fusion proteins and multispecific antibodies are often limited by protein production challenges. 3,4 Chemical-based transient transfection relies on condensation and either encapsulation or complexation of plasmid DNA by a b -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology